Extract notice to the Minister
Riva-Dapagliflozin
Common name / Subject : dapagliflozine (insuffisance cardiaque, fraction d'éjection >40%)
Name of the manufacturer : Riva
Form :
Dosage :
Name of the manufacturer : Riva
Form :
Dosage :
Indication :
INESSS' Recommendation
Inscription – Sous conditions
Minister's decisions
Inscrire sur les listes des médicaments - Médicament d'exception (2026-04-01)
Evaluation published on April 01, 2026